Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery

In a webinar brought to you by Bio-Techne and The Scientist, Dr. Jennifer Johnston discusses the past 20 years of her career, and how her basic research into ubiquitin-proteasome system elements—including Parkin E3 ligase—continues to provide the insight needed to move gene therapy and small molecule therapeutics toward the clinic.

Watch it here.

__________

Contact NysnoBio to get involved or learn more:
info@nysnobio.com

Previous
Previous

NysnoBio Awarded Michael J. Fox Foundation Grant for First Clinical Study

Next
Next

William Langston, NysnoBio SAB Member, discusses susceptibility to Parkinson's disease.